Business Description

OrthoLite is the world’s leading developer and supplier of open-cell foam technology used in over 400 million pairs of shoes made annually by 250 of the world’s leading footwear brands.

Value Creation

First Institutional Capital

Partnered with an entrepreneur-owned business with significant value creation potential.

Supply Chain / Asian Strategies

Blue Point’s efforts to expand OrthoLite’s manufacturing and sourcing in Asia allowed the Company to successfully accommodate its rapid growth. OrthoLite grew from one facility in each of China and Vietnam to four in China, two in Vietnam, a joint venture in Indonesia and the initial formation of a joint venture in India in just 3.5 years. During this time, OrthoLite also completed the construction of a second foaming facility and developed a sophisticated capacity utilization model – both of which supported significant revenue growth. Blue Point and OrthoLite’s management team aimed accommodate growth while increasing customer service and touchpoints to strengthen customer loyalty.

Human Capital

During Blue Point’s hold, OrthoLite deepened its management team by filling several C-suite positions and hiring middle management positions across all key functional areas. The Company also established a robust Sales & Marketing department to help diversify its customer base. Blue Point and the OrthoLite management team focused on improving its manufacturing, purchasing, subcontracting and logistics functions in addition to developing monthly management KPIs to effectively measure performance.

Blue Point’s complete list of investments is available upon request.